Related Experiment Video
Updated: Apr 30, 2026

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Case-control study of factors that trigger inflammatory bowel disease flares
Linda A Feagins1, Ramiz Iqbal1, Stuart J Spechler1
1Linda A Feagins, Ramiz Iqbal, Stuart J Spechler, VA North Texas Healthcare System, Dallas, TX 75216, United States.
Medication non-adherence is a significant trigger for inflammatory bowel disease (IBD) flares. Improving adherence may reduce IBD flare frequency and severity.
Area of Science:
- Gastroenterology
- Immunology
- Clinical Medicine
Background:
- Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are chronic conditions characterized by recurrent flares.
- Identifying triggers for IBD flares is crucial for effective disease management and improving patient quality of life.
Purpose of the Study:
- To investigate potential triggers associated with acute flares in patients with inflammatory bowel diseases.
- To determine the relationship between various factors and the occurrence of IBD flares.
Main Methods:
- A cohort of 134 patients with IBD (63 Crohn's disease, 70 ulcerative colitis) were enrolled, including 66 in flare and 68 in remission.
- Participants were systematically queried about potential triggers such as NSAID use, antibiotics, stress, smoking, medication adherence, infections, and travel.
- Multivariate regression analysis was employed to identify significant associations between triggers and IBD flares, with disease activity scores calculated.
Main Results:
- Medication non-adherence was significantly more frequent in patients experiencing IBD flares compared to controls (48.5% vs 29.4%, P = 0.03).
- Non-adherence remained a significant predictor of flares on multivariate analysis (OR = 2.86).
- Conversely, the use of immunomodulators was associated with a significantly lower rate of IBD flares (OR = 0.40).
Conclusions:
- Medication non-adherence emerged as a significant and independent risk factor for inflammatory bowel disease flares.
- These findings underscore the importance of improving medication adherence strategies in managing IBD.
- Immunomodulator therapy may play a protective role in preventing IBD flares.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

